Home Cart Sign in  
Chemical Structure| 59870-68-7 Chemical Structure| 59870-68-7

Structure of Glabridin
CAS No.: 59870-68-7

Chemical Structure| 59870-68-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Glabridin has many biological functions such as regulating the synthesis and activity of iNOS under high-glucose levels, significantly inhibiting free radicals generated during metabolism in the body, and protecting against oxidation-sensitive biomacromolecules (LDL, LDL, DNA) and cell walls. It is a natural product isolated and purified from the roots of Glycyrrhiza glabra L. with whitening and anti-aging activity.

Synonyms: Q-100692; KB-289522; LS-176045

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Glabridin

CAS No. :59870-68-7
Formula : C20H20O4
M.W : 324.37
SMILES Code : OC1=CC=C([C@H]2CC3=CC=C4C(C=CC(C)(C)O4)=C3OC2)C(O)=C1
Synonyms :
Q-100692; KB-289522; LS-176045
MDL No. :MFCD03427694
InChI Key :LBQIJVLKGVZRIW-ZDUSSCGKSA-N
Pubchem ID :124052

Safety of Glabridin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Peripheral blood mononuclear cells (PBMCs) 20 μM 1 hour Glabridin effectively inhibited the activation of IRF3 in PBMCs and reduced the expression of IFN-β, IL-6, and TNF-α. Mol Med. 2023 Dec 8;29(1):167
Bone-marrow-derived macrophages (BMDMs) 20 μM 1 hour Glabridin significantly inhibited the activation of STING and IRF3 in BMDMs and reduced the expression of IFN-β, IL-6, and TNF-α. Mol Med. 2023 Dec 8;29(1):167
RAW264.7 cells 10 μM and 20 μM 24 hours To evaluate the anti-inflammatory effect of GLA, results showed that GLA significantly inhibited NO secretion by macrophages. Adv Sci (Weinh). 2025 May;12(18):e2407802
Peripheral blood mononuclear cells (PBMCs) 20 μM 1 hour To verify the broad-spectrum inhibitory effect of Glabridin on the cGAS-STING signaling pathway. Results showed that Glabridin effectively inhibited cGAMP and diABZI-induced IRF3 activation and reduced the gene expression of IFN-β, IL-6, and TNF-α. Mol Med. 2023 Dec 8;29(1):167
Bone-marrow-derived macrophages (BMDMs) 20 μM 1 hour To evaluate the effect of Glabridin on the cGAS-STING signaling pathway. Results showed that Glabridin significantly inhibited HT-DNA-induced activation of STING and IRF3, and reduced the gene expression of IFN-β, IL-6, and TNF-α. Mol Med. 2023 Dec 8;29(1):167
T. gondii RH strain tachyzoites 5 µg/ml 24 and 48 hours To evaluate the inhibitory effects of glabridin on T. gondii tachyzoites, results showed significant inhibition of proliferation and invasion, along with structural damage. Parasit Vectors. 2024 Dec 18;17(1):522
Vero cells 5 µg/ml 24 hours To evaluate the cytotoxicity of glabridin on Vero cells, results showed 99.05% cell viability at 5 µg/ml with no significant toxicity. Parasit Vectors. 2024 Dec 18;17(1):522
Human platelets 5–30 µM 3 minutes Inhibited collagen-induced platelet aggregation Chin Med. 2023 Jun 10;18(1):71
Human cutaneous T-cell lymphoma cell line H9 0, 2.5, 5, 10, 20, 40, 80 μM 24 hours To evaluate the effect of Glabridin on CTCL cell viability, results showed that Glabridin significantly inhibits cell viability and induces programmed cell death (apoptosis, autophagy, and necrosis). Cell Prolif. 2024 Sep;57(9):e13701
Human cutaneous T-cell lymphoma cell line HH 0, 2.5, 5, 10, 20, 40, 80 μM 24 hours To evaluate the effect of Glabridin on CTCL cell viability, results showed that Glabridin significantly inhibits cell viability and induces programmed cell death (apoptosis, autophagy, and necrosis). Cell Prolif. 2024 Sep;57(9):e13701
Human platelets 20 and 30 µM 3 minutes Inhibited phosphorylation of Lyn, Fyn, Syk, and integrin β3 Chin Med. 2023 Jun 10;18(1):71

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice Trex1-deficient mice Intraperitoneal injection 40 mg/kg Daily for 14 days Glabridin significantly alleviated the inflammatory response in Trex1-deficient mice and reduced the expression of IFN-β, CXCL10, ISG15, IL-6, and TNF-α in various tissues. Mol Med. 2023 Dec 8;29(1):167
C57BL/6J mice DMXAA-induced cGAS-STING signaling pathway activation model Intraperitoneal injection 20 or 40 mg/kg Single injection, lasting 4 hours To study the inhibitory effect of Glabridin on the cGAS-STING signaling pathway in vivo. Results showed that Glabridin significantly reduced the levels of IFN-β, IL-6, and TNF-α in serum and peritoneal lavage fluid induced by DMXAA. Mol Med. 2023 Dec 8;29(1):167
Sprague-Dawley rats High-fat diet combined with streptozotocin-induced diabetic nephropathy model Intraperitoneal injection 50 mg/kg Once daily for 28 consecutive days To investigate the protective effect of Glabridin on diabetic nephropathy in rats, results showed that Glabridin could improve renal function, alleviate renal pathological changes, inhibit oxidative stress and ferroptosis, and exert its effects by regulating the VEGF/Akt/ERK pathway. Mol Med. 2022 May 20;28(1):58
BALB/c mice T. gondii RH strain infection model Oral gavage 50 mg/kg and 100 mg/kg 7 consecutive days To evaluate the effect of glabridin on the survival rate of T. gondii-infected mice, results showed that 100 mg/kg dose significantly prolonged survival time, with 20% of mice surviving until day 25 post-infection. Parasit Vectors. 2024 Dec 18;17(1):522
ICR mice Acute pulmonary thromboembolism model Intraperitoneal injection 6 and 12 mg/kg Single dose Reduced thrombus formation in lung vessels Chin Med. 2023 Jun 10;18(1):71

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.08mL

0.62mL

0.31mL

15.41mL

3.08mL

1.54mL

30.83mL

6.17mL

3.08mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

[1]Yehuda I, Madar Z, et al. Glabridin, an isoflavan from licorice root, downregulates iNOS expression and activity under high-glucose stress and inflammation. Mol Nutr Food Res. 2015 Jun;59(6):1041-52.

[2]Hsieh MJ, Lin CW, et al. Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells. Br J Pharmacol. 2014 Jun;171(12):3037-50.

[3]Hespeler D, Kaltenbach J, Pyo SM. Glabridin smartPearls - Silica selection, production, amorphous stability and enhanced solubility. Int J Pharm. 2019 Apr 20;561:228-235. doi: 10.1016/j.ijpharm.2019.02.028. Epub 2019 Mar 2. PMID: 30836152.

[4]Li LJ, Li GW, Xie Y. Zhongguo Zhong Yao Za Zhi. 2019;44(17):3786-3791.

[5]Mu J, Zhu D, Shen Z, Ning S, Liu Y, Chen J, Li Y, Li Z. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells. BMC Cancer. 2017 May 2;17(1):307. doi: 10.1186/s12885-017-3298-1. PMID: 28464803; PMCID: PMC5414299.

[6]Hsieh MJ, Lin CW, Yang SF, Chen MK, Chiou HL. Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells. Br J Pharmacol. 2014 Jun;171(12):3037-50. doi: 10.1111/bph.12626. Erratum in: Br J Pharmacol. 2017 May;174(9):909-910. PMID: 24641665; PMCID: PMC4055204.

[7]Huang HL, Hsieh MJ, Chien MH, Chen HY, Yang SF, Hsiao PC. Glabridin mediate caspases activation and induces apoptosis through JNK1/2 and p38 MAPK pathway in human promyelocytic leukemia cells. PLoS One. 2014 Jun 5;9(6):e98943. doi: 10.1371/journal.pone.0098943. PMID: 24901249; PMCID: PMC4047044.

[8]Kwon HS, Oh SM, Kim JK. Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin Exp Immunol. 2008 Jan;151(1):165-73. doi: 10.1111/j.1365-2249.2007.03539.x. Epub 2007 Nov 14. PMID: 18005263; PMCID: PMC2276918.

 

Historical Records

Categories